Seres Therapeutics, Inc. (MCRB)

SEC filing

Seres Therapeutics, Inc.

MCRB · CIK 1609809

4 · Aug 18, 2026 · Director Shaff Eric D. sold 263 shares at $4.55/share ($1,197); exercised options for 1,444 shares

Director Shaff Eric D. sold 263 shares at $4.55/share ($1,197); exercised options for 1,444 shares

xslF345X06/ownership.xml

xslF345X06/ownership.xmlSEC.gov

Graphics and non-inline formats (not embedded below).